Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Eur J Prosthodont Restor Dent ; 31(3): 214-223, 2023 Aug 31.
Artigo em Inglês | MEDLINE | ID: mdl-36515423

RESUMO

OBJECTIVE: The antimicrobial effect of prosthetic materials treated with chitosan was systematically reviewed. METHODS: The searches were carried out on PubMed/Medline, Scopus, ISI Web of Science, LILACS, Embase, and Open Grey with searches performed in March 2022. Selection of in vitro studies, data extraction and risk of bias analysis were performed following the PRISMA guidelines and registered at the Open Science Framework. The evaluated prosthetic materials corresponded to PMMA and tissue conditioner, treated with chitosan. RESULTS: After evaluating the eligibility criteria, 11 articles were included for the qualitative synthesis. The evaluated prosthetic materials corresponded to PMMA (n=8) and tissue conditioner (n=3). All studies performed the incorporation of chitosan in the tissue conditioner (n=3). Regarding PMMA, the use of chitosan as a denture cleanser was the most used (n=3), followed by incorporation (n=2), multilayers coating onto PMMA (n=2) and denture adhesive for PMMA (n=1). Chitosan has antimicrobial activity and is effective in the treatment of prosthetic materials in most studies, but it depends on some factors, such as the treatment method, the type and characteristics of the chitosan, the microorganism evaluated, and its form of organization. CONCLUSION: Chitosan showed highly antimicrobial activity and was effective when used in prosthetic materials.


Assuntos
Anti-Infecciosos , Quitosana , Quitosana/farmacologia , Polimetil Metacrilato , Anti-Infecciosos/farmacologia , Teste de Materiais
2.
Trans R Soc Trop Med Hyg ; 91(1): 25-7, 1997.
Artigo em Inglês | MEDLINE | ID: mdl-9093620

RESUMO

Ten Trypanosoma cruzi stocks recently isolated from patients in acute and chronic phases of Chagas disease were inoculated to susceptible (A/Sn) mice. The mice were inoculated with 10(4) trypomastigotes intraperitoneally and monitored for parasitaemia and mortality for up to 300 d. The results demonstrated that (i) T. cruzi stocks isolated from patients in the acute phase killed animals, while stocks from patients in the chronic phase did not; (ii) survival curves differed statistically among mice infected with lethal stocks, and (iii) parasite burden did not affect the mortality rate of mice.


Assuntos
Doença de Chagas/parasitologia , Parasitemia/parasitologia , Trypanosoma cruzi/patogenicidade , Doença Aguda , Adolescente , Adulto , Animais , Criança , Doença Crônica , Feminino , Humanos , Lactente , Masculino , Camundongos , Pessoa de Meia-Idade , Análise de Sobrevida , Trypanosoma cruzi/isolamento & purificação
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA